fromMedCity News1 week agoThe Myth of All-American Drugs and What Trump's Tariffs Miss About Pharma Supply Chains - MedCity NewsNkarta's cell therapies face potential impact from pharmaceutical tariffs affecting supply chain costs and availability of key materials.
US newsfromNature1 month agoUS-China trade conflict threatens biomedical collaborationUS-China trade conflict hampers biomedical research in China, delaying projects and increasing costs.
fromwww.berkeleyside.org1 month agoGoing green: Bayer's newest Berkeley facility earns LEED platinumBayer's new facility in Berkeley received LEED Platinum certification and the Facility of the Year Award for its advancement in sustainable pharmaceutical manufacturing.
CancerfromNature2 months agoHow CAR-T cancer therapies could harm the brainCell therapies for cancer can trigger harmful immune responses affecting the brain.Study results in mice may inform safer cancer treatment strategies in humans.
London startupfromwww.theguardian.com4 months agoAstraZeneca pays up to $1bn for biotech firm that could transform cell therapy'AstraZeneca's $1bn acquisition of EsoBiotec aims to enhance access to rapid cell therapies for cancer treatment.